Compile Data Set for Download or QSAR
Report error Found 694 for UniProtKB: O14929
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764596(US20250257055, Example 34 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764595(US20250257055, Example 33 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764595(US20250257055, Example 33 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764596(US20250257055, Example 34 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764573(US20250257055, Example 10 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764594(US20250257055, Example 32 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764573(US20250257055, Example 10 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764594(US20250257055, Example 32 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764567(US20250257055, Example 4 | US20250263415, Example ...)
Affinity DataIC50: 0.5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764567(US20250257055, Example 4 | US20250263415, Example ...)
Affinity DataIC50: 0.5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764566(US20250257055, Example 3 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764572(US20250257055, Example 9 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764572(US20250257055, Example 9 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764566(US20250257055, Example 3 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764570(US20250257055, Example 7 | US20250263415, Example ...)
Affinity DataIC50: 0.900nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764570(US20250257055, Example 7 | US20250263415, Example ...)
Affinity DataIC50: 0.900nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764593(US20250257055, Example 31 | US20250263415, Example...)
Affinity DataIC50: 1nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764593(US20250257055, Example 31 | US20250263415, Example...)
Affinity DataIC50: 1nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM757557(6-(Dimethylamino)-N-((2-methylquinolin-8-yl)sulfon...)
Affinity DataIC50: 1.47nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764592(US20250257055, Example 30 | US20250263415, Example...)
Affinity DataIC50: 1.5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764583(US20250257055, Example 20 | US20250263415, Example...)
Affinity DataIC50: 1.70nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764574(US20250257055, Example 11 | US20250263415, Example...)
Affinity DataIC50: 2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764592(US20250257055, Example 30 | US20250263415, Example...)
Affinity DataIC50: 2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764580(US20250257055, Example 17 | US20250263415, Example...)
Affinity DataIC50: 2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764583(US20250257055, Example 20 | US20250263415, Example...)
Affinity DataIC50: 2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764574(US20250257055, Example 11 | US20250263415, Example...)
Affinity DataIC50: 2.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM757469(US12357603, Example 107)
Affinity DataIC50: 2.29nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764580(US20250257055, Example 17 | US20250263415, Example...)
Affinity DataIC50: 2.30nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM757546(N-((5-(tert-butyl)-2-methoxyphenyl)sulfonyl)-6-(di...)
Affinity DataIC50: 2.63nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM757543(N-[(5-(tert-butyl)-2-cyclobutoxyphenyl)sulfonyl]-6...)
Affinity DataIC50: 2.67nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764591(US20250257055, Example 29 | US20250263415, Example...)
Affinity DataIC50: 2.80nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM764591(US20250257055, Example 29 | US20250263415, Example...)
Affinity DataIC50: 3nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM757588(US12357603, Example 227)
Affinity DataIC50: 4nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM757541(N-((5-(tert-butyl)-2-(cyclopropylmethoxy)phenyl)su...)
Affinity DataIC50: 4.36nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM757532(6-(Dimethylamino)-N-(2-ethoxy-5-sec-butyl-phenyl)s...)
Affinity DataIC50: 4.40nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM757431(US12357603, Example 69)
Affinity DataIC50: 4.5nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM757470(US12357603, Example 108)
Affinity DataIC50: 4.60nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM764576(US20250257055, Example 13 | US20250263415, Example...)
Affinity DataIC50: 5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764597(US20250257055, Example 35 | US20250263415, Example...)
Affinity DataIC50: 5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764597(US20250257055, Example 35 | US20250263415, Example...)
Affinity DataIC50: 5.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764576(US20250257055, Example 13 | US20250263415, Example...)
Affinity DataIC50: 5.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764588(US20250257055, Example 25 | US20250263415, Example...)
Affinity DataIC50: 5.70nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

LigandPNGBDBM757556(6-(Dimethylamino)-N-((2-ethoxyphenyl)sulfonyl)-4-(...)
Affinity DataIC50: 5.73nMAssay Description:Recombinant human His-tagged Kat6a protein (amino acids 194-810), was purified in-house from Baculovirus-infected insect cells (Sf9). Histone H4 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

LigandPNGBDBM764588(US20250257055, Example 25 | US20250263415, Example...)
Affinity DataIC50: 6nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764575(US20250257055, Example 12 | US20250263415, Example...)
Affinity DataIC50: 6nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764578(US20250257055, Example 15 | US20250263415, Example...)
Affinity DataIC50: 6nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

LigandPNGBDBM764568(US20250257055, Example 5 | US20250263415, Example ...)
Affinity DataIC50: 6nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764568(US20250257055, Example 5 | US20250263415, Example ...)
Affinity DataIC50: 6.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764578(US20250257055, Example 15 | US20250263415, Example...)
Affinity DataIC50: 6.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764575(US20250257055, Example 12 | US20250263415, Example...)
Affinity DataIC50: 6.30nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

Displayed 1 to 50 (of 694 total ) | Next | Last >>
Jump to: